Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Apellis: FDA Accepts & Grants Priority Review Designation For Pegcetacoplan NDA For Paroxysmal Nocturnal Hemoglobinuria


RTTNews | Nov 16, 2020 07:11AM EST

07:11 Monday, November 16, 2020 (RTTNews) - Apellis: FDA Accepts & Grants Priority Review Designation For Pegcetacoplan NDA For Paroxysmal Nocturnal Hemoglobinuria

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC